Sue Dehnam

Cannabis operators aren’t alone in worrying about consolidation. Consumers interviewed across nine established adult-use markets praised legalization for improving safety, access, and social acceptance, but many also saw regulatory costs and corporate concentration pushing small businesses aside. Participants also questioned whether cannabis tax revenue has delivered promised community benefits and worry large corporations eventually could shape policy in their favor.

A small study associated frequent cannabis use with higher waking cortisol, but found no difference in the cortisol awakening response and did not establish causation.

Senate Democrats have revived CAOA, a sweeping bill that would deschedule cannabis entirely and address several consequences of federal prohibition. Its previous versions went nowhere.

Most of the 21 hemp THC beverages tested by a nonprofit missed their label claims, adding an inconvenient new wrinkle to the industry’s argument for regulation instead of prohibition.

Trulieve will begin trading on the NYSE after executing a strategic corporate restructuring to maintain a 100-percent medical consolidated footprint.

Curaleaf Holdings is making its most tangible move yet toward a major U.S. stock exchange listing with a reverse split of its subordinate shares.

Splash Beverage Group (NYSE: SBEV) appoints Sunburn Cannabis CEO Brady Cobb to lead its strategic pivot from alcohol to the high-growth cannabinoid and regulated wellness sectors.

In a move that signals massive consolidation in the B2B events space, Apollo Global Management has agreed to acquire Emerald Holding Inc. — parent company of MJBizCon — in a $1.5-billion all-cash deal. The transaction will take the publicly traded Emerald private, merging its portfolio with Questex LLC to create a unified experiential media platform. While the deal reflects Apollo’s broader interest in specialized markets rather than a specific cannabis play, the shift raises critical questions about the future of the industry’s largest trade show. Will MJBizCon thrive under new institutional ownership, or drift within a larger, more diverse portfolio?

The DEA isn’t stepping back; it’s stepping in. While the industry celebrates the end of 280E, the fine print of the new Schedule III order reveals a mandatory federal middleman, undisclosed fees, and a legal “prescription” trap that could leave dispensaries in limbo. Here is what the rescheduling order actually means for your bottom line.

WEST HOLLYWOOD, Calif. – The cannabis industry is quick to celebrate sales figures and product launches, the popular players, and celebrity partnerships. Less often...